Home > Boards > US Listed > Medical - Drugs >

Seelos Therapeutics Inc (SEEL)

Add SEEL Price Alert      Hide Sticky   Hide Intro
Search This Board: 
Last Post: 10/1/2019 8:05:27 PM - Followers: 231 - Board type: Free - Posts Today: 0

Apricus Biosciences, Inc. (APRI) 








Company Address:

11975 El Camino Real, Suite 300
San Diego, CA 92130
T (858) 222-8041

 CIK:   0001017491

Apricus Website:    http://www.apricusbio.com/index.html



NexACT® - Multi-Route Drug Delivery Technology

NexACT® Multi-Route drug delivery technology facilitates compounds crossing the lipid bilayer and yet biodegrades in vivo to natural amino acids and natural fatty acids.

This technology is useful for:
  • Penetrating, proprietary, topical & transdermal formulations.
    Improving oral bioavailability of poorly soluble, poorly permeating compounds (BCS class 2-4)
    Delivering siRNA therapeutics into the cells; in vivo validated
    Development of more effective, penetrating cosmeceutic formulations

The safety and permeation properties of this proprietary drug delivery technology was demonstrated in the Vitaros® product which was approved for the treatment of erectile dysfunction in November 2010 by Health Canada, and approved by the European Union in June 2013.  Vitaros has been launched in all European Union countries by partner pharmaceutical companies.  Additional agreements for marketing Vitaros have been established.  For more information see the company's most recent 10K SEC filing.

In September 2015 the company anounced an agreement with Allergan to reacquire marketing rights for Vitaros in the U.S.  The company expects to resubmit a filing for FDA approval of Vitaros in the second half of 2016.  For more information see the company's most recent 10K SEC filing.

The company expects to initiate a Phase IIb clinical trial for RayVa to treat Reynaud's Syndrome in the second half of 2016.

In October 2014, the company acquired U.S. development and licensing rights to Fispemifene, a Selective Estrogen-Receptor Modulator (SERM) for treatment of secondary hypogonadism.  In March 2016 the company discontinued development Fispemifene after disappointing Phase IIb results.

 Filings:  http://www.sec.gov/cgi-bin/browse-edgar?company=&match=&CIK=0001017491&filenum=&State=&Country=&SIC=&owner=exclude&Find=Find+Companies&action=getcompany

Share Structure:
Outstanding Shares

Authorized Shares

Investor Relations:
Tel: +1-858 222-8041

Matthew Beck
The Trout Group
:(646)378 2933




All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.


Please keep your posts on topic because your message(s) will probably be deleted when:
* Posting content that's off-topic to the subject of this board;
* Posting statements that don't add value to the discussion; or
* When you violate any other posting term of the iHub User Agreement: http://investorshub.advfn.com/boards/complex_terms.asp


Image result for vitaros                                                  

Image result for vitaros

Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
SEEL News: Seelos Therapeutics Announces Amendment of SLS-002 Agreement 10/21/2019 09:00:05 AM
SEEL News: Current Report Filing (8-k) 10/21/2019 08:58:07 AM
SEEL News: Seelos Therapeutics to Participate in Upcoming Investor Conference in November 10/18/2019 09:00:00 AM
SEEL News: Seelos Therapeutics Announces the Addition of Scott Applebaum as Lead Strategic Regulatory Consultant 10/15/2019 09:00:00 AM
SEEL News: Seelos Therapeutics to Participate in Upcoming Investor Conference in September 09/04/2019 09:00:00 AM
#29708   Those of you that waiting for something to dinogreeves 10/01/19 08:05:27 PM
#29707   News: $SEEL Seelos Therapeutics Announces Pricing of $6.7 whytestocks 08/23/19 09:10:28 AM
#29706   $SEEL 3 months chart $Pistol Pete$ 08/12/19 07:40:25 PM
#29705   Seelos shares set to soar. Seeking Alpha article Boneride 07/23/19 12:00:00 PM
#29704   Well she sure trades like shit food4thought 06/28/19 03:26:54 PM
#29703   FDA meeting https://www.youtube.com/watch?v=5pXHyhML_qw&feature=youtu.be booktrader 06/28/19 03:23:57 PM
#29702   SEEL added to russell https://www.ftserussell.com/files/support-document/2019-pr booktrader 06/28/19 03:22:33 PM
#29701   https://www.youtube.com/watch?v=-fZ26jf7RWY booktrader 06/28/19 03:21:24 PM
#29700   Right. I hope you recover everything. Cheers. $avvyPenny$tockInvestor™ 06/27/19 10:18:18 AM
#29699   Cheers my man. I agree. Always better to food4thought 06/27/19 09:46:45 AM
#29698   I know. Even though the news is real, $avvyPenny$tockInvestor™ 06/27/19 09:24:55 AM
#29697   Wonderful News!!!! Seelos Therapeutics acquires gene therapy program license aks_v 06/27/19 09:03:59 AM
#29696   It’s retracting, but the news real, volume is food4thought 06/27/19 08:46:48 AM
#29695   Bro...be careful. They pumped this up. Looks like $avvyPenny$tockInvestor™ 06/27/19 08:39:38 AM
#29694   Let’s run! food4thought 06/27/19 08:38:27 AM
#29693   Well, it is certainly annoying. However, we Leonard McKinley 06/18/19 01:58:19 PM
#29692   Early stage bios....never fails. No matter how good food4thought 06/18/19 11:13:48 AM
#29691   I knew it. Sonofabitches!!! food4thought 06/18/19 11:13:11 AM
#29690   The 8K filed today confirms my worst fear. Leonard McKinley 06/18/19 08:29:22 AM
#29689   Mods would be nice to keep the weed trickledownfacists 06/14/19 07:28:03 PM
#29688   Well, I wish I had entered ENLV when food4thought 06/14/19 04:01:23 PM
#29687   Don't feel bad. I sold 1 pos to Boneride 06/14/19 02:23:15 PM
#29686   SVRA down 75% after hours to $3. $6.21 Boneride 06/13/19 12:48:48 AM
#29685   My pleasure. The instant I see Diageo, Pernod Boneride 06/12/19 02:40:11 PM
#29684   Thanks boner. I’ll watch. Once legislation passes and food4thought 06/12/19 11:37:13 AM
#29683   iAnthus is almost at a 52-week low now Boneride 06/12/19 10:57:45 AM
#29682   The cannabis sector has been beat back due food4thought 06/12/19 09:05:29 AM
#29681   AND, a pharmaceutical co. partnering with a pot Boneride 06/11/19 05:51:32 PM
#29680   Just a prediction since Jakob Ripstein, now Aphria's Boneride 06/11/19 05:33:43 PM
#29679   How do you know of that collaboration /partnership? food4thought 06/11/19 11:14:44 AM
#29678   Do yourselves a favor, folks. When Diageo partners Boneride 06/11/19 11:00:31 AM
#29677   So, you did explain it. Boneride 06/10/19 04:24:54 PM
#29676   No explanation needed..... Typical biotech with trial stagnation, price food4thought 06/10/19 03:37:43 PM
#29675   Can anyone explain this abortion ? Boneride 06/10/19 03:10:07 PM
#29674   Mr. M., I wish I knew half as Boneride 06/09/19 12:35:32 AM
#29673   The company presented at the Jeffries conference, and Leonard McKinley 06/08/19 03:04:00 PM
#29672   So the E.T. look-a-like didn't win over investors Boneride 06/07/19 10:22:03 AM
#29671   u pretty cool, siwwy wabbit !! Just hold Boneride 06/06/19 02:40:31 PM
#29670   Not funny...lol rabbit67 06/06/19 11:20:41 AM
#29669   Mississippi rednecks mowing their lawns in the rain Boneride 06/06/19 10:30:42 AM
#29668   Lmao...hmmmmm.. Oh hey you can plagerise this also... rabbit67 06/04/19 08:18:24 PM
#29667   Well now.....10% day. Things that make you food4thought 06/03/19 06:26:55 PM
#29666   Like I care what you think, Lumpo. Another Boneride 06/02/19 12:52:04 AM
#29665   I am a SEEL shareholder, and am embarrassed lumpy9200 06/01/19 12:43:58 AM
#29663   Don't agree it's early stage but I will Boneride 05/29/19 11:40:14 PM
#29662   I bought some too so you shall not food4thought 05/29/19 03:34:07 PM
#29661   Will hold til the bitter end only as Boneride 05/29/19 02:50:51 PM
#29660   Once again, a shockingly pathetic performance. Boneride 05/28/19 03:55:54 PM
#29659   Have a strong feeling positive news is around aks_v 05/26/19 02:33:13 PM
#29658   Same close 3 days in a row is Boneride 05/25/19 11:29:22 PM